학술논문

Two-year efficacy and safety in abatacept-treated patients with RA who received continuous therapy or switched from infliximab to abatacept: the ATTEST trial: 0851
Document Type
Academic Journal
Source
International Journal of Rheumatic Diseases. Jul 01, 2010 13 Suppl 1:104-104
Subject
Language
English
ISSN
1756-1841